• Dow's Merck Bails On Cholesterol Drug, Prodding Shares Down

    Source: NASDAQ Stocks / 11 Oct 2017 19:59:05   Eastern Standard Time

    Dow component Merck MRK said late Wednesday that it won t submit applications for approval of a cholesterol drug following a review of its clinical profile 160 prodding shares to fall in after hours trading ibd display video id 2350371 width 50 float http://articlefeeds.nasdaq.com/~r/nasdaq/categories/~3/PRr-6mQGRpA/dows-merck-bails-on-cholesterol-drug-prodding-shares-down-cm858495